Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Wells-Fargo conference in detail
read here
Wells-Fargo conf updates
Insightful remarks @ Wells Fargo Securities Research Economics Healthcare
read here
Morgan-Stanley Conference updates
Read here
http://www.earningsimpact.com/Transcript/81937/RY/Royal-Bank-of-Canada---2013-Morgan-Stanley-Financials-Conference
Business Update
Business update on MELA Sciences and certain preliminary activities that the leadership team is undertaking.
Read-here
Must read - -Morgan Stanley Financials Conference updates
read here
2013 Morgan Stanley Financials Conference
Insightful remarks @ conference
read here
Morgan-Stanley-Financials-Conference updates
Read here
http://www.earningsimpact.com/Transcript/81940/IVR/Invesco-Mortgage-Capital-Inc---2013-Morgan-Stanley-Financials-Conference
Insightful presentation @ Goldman sachs
Read-here
Jefferies Conference in detail
Insightful comments at Jefferies-2013-Global-Healthcare-Conference
read here
Jefferies Global Healthcare Conference
Currently running 7 randomized studies and 7 indications
read here
Details abt LBLP-25 & ONT-10 @ Jefferies Global Healthcare Conference
read here
http://www.earningsimpact.com/Transcript/82060/ONTY/Oncothyreon-Inc---Jefferies-2013-Global-Healthcare-Conference
Lazard Capital Conf Call.
Details about Xyrem as standard of care @ Lazard Capital Conf Call.
read-here
Annual-Oppenheimer Conference
55% of the registered vehicles are light trucks or SUVs
read here
Updates on pimavanserin with Allergan at JMP Securities Conf.
Read here
Business Update Call
Details about growing NUEDEXTA PBA & other updates
Read here
Bank-of-America-Merrill-Lynch Conf Updates
Valauble comments..
Read here
Merrill-Lynch-Global-Technology-Conference Updates
Read here
Merrill-Lynch Technology-Conference
Conference Updates are interesting...
Transcript here
Bank of America Global Technology Conference
Hard to find such a valuable read..
read here
Bank-of-America Technology-Conference
Updates can be found here
Read here
Bank of America Merrill Lynch Conference Updates
Notable remarks.. Must read
Read here
Interesting remarks at Jefferies Healthcare Conference
Read here
Merger Conference Call details
MB Financial and Taylor Capital to Merge.. Conference call updates
Read here
Jefferies Conference Presentation
Interesting comments at Jefferies-2013-Global-Healthcare-Conference
read here
Jefferies Conference Presentation
Interesting comments at Jefferies-2013-Global-Healthcare-Conference
read here
Lazard's Solid State Storage Day Conference
Hard to find.. valuable read..
Transcript here
Investor-Forum Transcript
This one is a very insightful read..
Read here
Discuss at Wells Fargo Conference
Interesting remarks at Healthcare conference
Read here
Bank-of-America-Merrill-Lynch Conference in detail
Read here in detail.. conf transcript
Read here
Credit-Suisse-Conference
Interesting comments... read here
http://www.earningsimpact.com/Transcript/81965/NS/Nustar-Energy-L-P----2013-Credit-Suisse-MLP-and-Energy-Logistics-Conference
Presentation at GHS 100
Insightful presentation at GHS 100 conference..
Read here
Wells Fargo Conference
Discuss about aHUS & more at conference..
Read here
William-Blair Conference updates
Insightful read....
Read here
Business Update Call Updates
New pivotal trail for solanezumab called EXPEDITION 3
Transcript here
Q2 2013 Earnings Call- Transcript
Earnings call at 11.00 am ET
Transcript here
Q2 2013 Earnings Call
Reports earnings today...
Transcript here
Business Update Call
Exit the bank, being regulated as a savings and loan holding company. talk about the related regulatory approval process and expected timing of the transaction
Transcript here
Ariad specializes in discovery and developing best-in-class kinase inhibitors for various cancers
The first approval was achieved late last year that is the drug is called Iclusig and the drug is for CML. It is a form of leukemia. The second candidate is called AP26113 and that drug in for lung cancer.
Read here